Results of prolonged treatment with pentolinium tartrate with special reference to the addition of Rauwolfia, hydralazine or both.
D000959:Antihypertensive Agents; D006830:Hydralazine / Q000627:therapeutic use*; D006973:Hypertension / Q000628:therapy*; D006993:Hypnotics and Sedatives; D009125:Muscle Relaxants, Central / Q000627:therapeutic use*; D010425:Pentolinium Tartrate; D011926:Rauwolfia; D046948:Secologanin Tryptamine Alkaloids / Q000627:therapeutic use*
D000959:Antihypertensive Agents; D006993:Hypnotics and Sedatives; D009125:Muscle Relaxants, Central; D046948:Secologanin Tryptamine Alkaloids; D006830:Hydralazine; D010425:Pentolinium Tartrate
HYDRALAZINE/therapeutic use; HYPERTENSION/therapy; MUSCLE RELAXANTS/therapeutic use; RAUWOLFIA ALKALOIDS/therapeutic use